{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T18:44:51Z","timestamp":1773081891002,"version":"3.50.1"},"reference-count":193,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Surgical Clinics of North America"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.suc.2012.01.015","type":"journal-article","created":{"date-parts":[[2012,3,10]],"date-time":"2012-03-10T15:55:05Z","timestamp":1331394905000},"page":"345-391","source":"Crossref","is-referenced-by-count":31,"title":["Multidrug-Resistant Organisms and Antibiotic Management"],"prefix":"10.1016","volume":"92","author":[{"given":"Philip S.","family":"Barie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.suc.2012.01.015_bib1","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S1473-3099(06)70689-2","article-title":"Anti-infective research and development\u2014problems, challenges, and solutions","volume":"7","author":"Bradley","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.suc.2012.01.015_bib2","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/jac\/dki229","article-title":"The resistance ratchet: theoretical implications of cyclic selection pressure","volume":"56","author":"Magee","year":"2005","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.suc.2012.01.015_bib3","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1086\/510393","article-title":"Infectious Diseases Society of America and Society of Healthcare Epidemiology. Infectious Diseases Society of America and Society of Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship","volume":"44","author":"Dellit","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.suc.2012.01.015_bib4","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1055\/s-0031-1275534","article-title":"Antibiotic stewardship in the intensive care unit","volume":"32","author":"Arnold","year":"2011","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.suc.2012.01.015_bib5","series-title":"The trauma manual. Trauma and acute care surgery","first-page":"596","article-title":"Infections of trauma patients","author":"Barie","year":"2008"},{"key":"10.1016\/j.suc.2012.01.015_bib6","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ijantimicag.2005.04.017","article-title":"A\u00a0systematic review and meta-analysis of misuse of antibiotic therapies in the community","volume":"26","author":"Kardas","year":"2005","journal-title":"Int J Antimicrob Agents"},{"issue":"11","key":"10.1016\/j.suc.2012.01.015_bib7","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1186\/1471-2458-11-538","article-title":"Non-prescribed sale of antibiotics in Riyadh, Saudi Arabia: a cross sectional study","volume":"7","author":"Bin Abdulhak","year":"2011","journal-title":"BMC Public Health"},{"key":"10.1016\/j.suc.2012.01.015_bib8","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1086\/598183","article-title":"The sale of antibiotics without prescription in pharmacies in Catalonia, Spain","volume":"48","author":"Llor","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.suc.2012.01.015_bib9","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1086\/533452","article-title":"Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE","volume":"197","author":"Rice","year":"2009","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.suc.2012.01.015_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/595011","article-title":"Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America","volume":"48","author":"Boucher","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.suc.2012.01.015_bib11","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ajic.2009.02.006","article-title":"Epidemiology of an outbreak of antibiotic-resistant Klebsiella pneumoniae at a tertiary care medical center","volume":"37","author":"Filozov","year":"2009","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.suc.2012.01.015_bib12","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1086\/499405","article-title":"Use of broad-spectrum antimicrobials for the treatment of pneumonia in seriously ill patients: maximizing clinical outcomes and minimizing selection of resistant organisms","volume":"42","author":"Niederman","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.suc.2012.01.015_bib13","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1097\/00003246-200010000-00014","article-title":"Inadequate treatment of nosocomial infections is associated with certain empiric antibiotic choices","volume":"28","author":"Kollef","year":"2000","journal-title":"Crit Care Med"},{"key":"10.1016\/j.suc.2012.01.015_bib14","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/BF01712153","article-title":"Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit: ICU-Acquired Pneumonia Study Group","volume":"22","author":"Alvarez-Lerma","year":"1996","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.suc.2012.01.015_bib15","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1097\/01.CCM.0000098031.24329.10","article-title":"Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis","volume":"31","author":"Garnacho-Montero","year":"2003","journal-title":"Crit Care Med"},{"issue":"12 Suppl 4","key":"10.1016\/j.suc.2012.01.015_bib16","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.2146\/090087d","article-title":"Rational dosing of antimicrobial agents: pharmacokinetic and pharmacodynamic strategies","volume":"66","author":"Owens","year":"2009","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.suc.2012.01.015_bib17","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0002-9610(97)89606-7","article-title":"Pharmacodynamics of antimicrobial therapy in surgery","volume":"171","author":"DiPiro","year":"1996","journal-title":"Am J Surg"},{"key":"10.1016\/j.suc.2012.01.015_bib18","article-title":"Reducing the development of antibiotic resistance in critical care units","author":"Deege","year":"2011","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.suc.2012.01.015_bib19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/10495390600957092","article-title":"Genetics of antimicrobial resistance","volume":"17","author":"Harbottle","year":"2006","journal-title":"Anim Biotechnol"},{"issue":"5 Suppl 1","key":"10.1016\/j.suc.2012.01.015_bib20","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.ajic.2006.05.238","article-title":"Resistance in gram-negative bacteria: Enterobacteriaceae","volume":"34","author":"Paterson","year":"2006","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.suc.2012.01.015_bib21","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2174\/187152606779025842","article-title":"The other target for ribosomal antibiotics: inhibition of bacterial ribosomal subunit formation","volume":"6","author":"Champney","year":"2006","journal-title":"Infect Disord Drug Targets"},{"key":"10.1016\/j.suc.2012.01.015_bib22","first-page":"171","article-title":"Extended-spectrum beta-lactamases (ESBLs): a global problem","volume":"38","author":"Al-Jasser","year":"2006","journal-title":"Kuwait Med J"},{"key":"10.1016\/j.suc.2012.01.015_bib23","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1128\/CMR.00040-09","article-title":"Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms","volume":"22","author":"Lister","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.suc.2012.01.015_bib24","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1128\/AAC.47.12.3675-3681.2003","article-title":"Ribosomal protection proteins and their mechanism of tetracycline resistance","volume":"47","author":"Connell","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.suc.2012.01.015_bib25","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1128\/MMBR.65.2.232-260.2001","article-title":"Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance","volume":"65","author":"Chopra","year":"2001","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.suc.2012.01.015_bib26","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1098\/rstb.1980.0049","article-title":"The structure of \u03b2-lactamases","volume":"289","author":"Ambler","year":"1980","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.suc.2012.01.015_bib27","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1128\/AAC.39.6.1211","article-title":"A\u00a0functional classification scheme for \u03b2-lactamases and its correlation with molecular structure","volume":"39","author":"Bush","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.suc.2012.01.015_bib28","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S1995-7645(12)60003-0","article-title":"Prevalence of plasmid-mediated bla(TEM-1) and bla(CTX-M-15) type extended spectrum beta-lactamases in patients with sepsis","volume":"5","author":"Haque","year":"2012","journal-title":"Asian Pac J Trop Med"},{"key":"10.1016\/j.suc.2012.01.015_bib29","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/BF01641355","article-title":"Transferable resistance to cefotaxime cefoxitin, cefamandole, and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens","volume":"11","author":"Knothe","year":"1983","journal-title":"Infection"},{"issue":"Suppl 2","key":"10.1016\/j.suc.2012.01.015_bib30","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1016\/j.ijantimicag.2010.11.014","article-title":"Multidrug-resistant Gram-negative bacteria: how to treat and for how long","volume":"36","author":"Giamarellou","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.suc.2012.01.015_bib31","first-page":"653","article-title":"Therapeutic options for infections with Enterobacteriaceae producing carbapenem-hydrolyzing enzymes","volume":"6","author":"Falagas","year":"2011","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.suc.2012.01.015_bib32","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1586\/eri.11.28","article-title":"Status report on carbepenemases: challenges and prospects","volume":"9","author":"Patel","year":"2011","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.suc.2012.01.015_bib33","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1128\/AAC.45.4.1151-1161.2001","article-title":"novel carbepenem-hydrolyzing beta-lactamase, KPC-1, for a carbepenem-resistant strain of Klebsiella pneumoniae","volume":"45","author":"Yigit","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.suc.2012.01.015_bib34","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1089\/mdr.2009.0031","article-title":"Antimicrobial susceptibility patterns of KPC-producing or CTX-M-producing Enterobacteriaceae","volume":"16","author":"Castanheira","year":"2010","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.suc.2012.01.015_bib35","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1086\/600042","article-title":"Infection with panresistant Klebsiella pneumoniae: a report of 2 cases and a brief review of the literature","volume":"49","author":"Elemam","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.suc.2012.01.015_bib36","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1128\/AAC.49.8.3538-3540.2005","article-title":"First nosocomial outbreak of Pseudomonas aeruginosa producing an integron-borne metallo-beta-lactamase (VIM-2) in the United States","volume":"49","author":"Lolans","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.suc.2012.01.015_bib37","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3109\/1040841X.2011.559944","article-title":"IMP-type metallo-\u03b2-lactamases in Gram-negative bacilli: distribution, phylogeny, and association with integrons","volume":"37","author":"Zhao","year":"2011","journal-title":"Crit Rev Microbiol"},{"key":"10.1016\/j.suc.2012.01.015_bib38","doi-asserted-by":"crossref","first-page":"5046","DOI":"10.1128\/AAC.00774-09","article-title":"Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India","volume":"53","author":"Yong","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.suc.2012.01.015_bib39","first-page":"147","article-title":"New Delhi Metallo-beta-lactamase-1 (NDM-1) in Enterobacteriaceae. Treatment options with carbapenems compromised","volume":"58","author":"Deshpande","year":"2010","journal-title":"J\u00a0Assoc Physicians India"},{"key":"10.1016\/j.suc.2012.01.015_bib40","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1128\/CMR.00036-08","article-title":"AmpC beta-lactamases","volume":"22","author":"Jacoby","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.suc.2012.01.015_bib41","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/jac\/dki482","article-title":"OXA-type carbepenemases","volume":"57","author":"Walther-Rasmussen","year":"2006","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.suc.2012.01.015_bib42","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.sbi.2011.05.005","article-title":"The structural biology of \u03b2-barrel membrane proteins: a summary of recent reports","volume":"21","author":"Fairman","year":"2011","journal-title":"Curr Opin Struct Biol"},{"key":"10.1016\/j.suc.2012.01.015_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijmm.2011.10.001","article-title":"Structure and function of OprD protein in Pseudomonas aeruginosa From antibiotic resistance to novel therapies","author":"Li","year":"2012","journal-title":"Int J Med Microbiol"},{"key":"10.1016\/j.suc.2012.01.015_bib44","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1128\/AAC.01198-06","article-title":"Tigecycline efflux as a mechanism for non-susceptibility in Acinetobacter baumannii","volume":"51","author":"Peleg","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.suc.2012.01.015_bib45","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.mib.2009.07.003","article-title":"Structure, function, and inhibition of RND efflux pumps in Gram-negative bacteria: an update","volume":"12","author":"Blair","year":"2009","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.suc.2012.01.015_bib46","first-page":"255","article-title":"Multidrug efflux pumps and antimicrobial resistance in Pseudomonas aeruginosa and related organisms","volume":"3","author":"Poole","year":"2001","journal-title":"J\u00a0Mol Microbiol Biotechnol"},{"key":"10.1016\/j.suc.2012.01.015_bib47","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/9780470920541.ch5","article-title":"Efflux pumps as an important mechanism for quinolone resistance","volume":"77","author":"Vila","year":"2011","journal-title":"Adv Enzymol Relat Areas Mol Biol"},{"key":"10.1016\/j.suc.2012.01.015_bib48","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10156-010-0120-2","article-title":"Plasmid-mediated quinolone resistance: an update","volume":"17","author":"Rodriguez-Jartinez","year":"2011","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.suc.2012.01.015_bib49","first-page":"49","article-title":"Antimicrobial susceptibility among Acinetobacter calcoaceticus-baumannii complex and Enterobacteriaceae collected as part of the Tigecycline Evaluation and Surveillance Trial","volume":"55","author":"Halstead","year":"2007","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.suc.2012.01.015_bib50","article-title":"Activity of tigecycline and comparators against skin and skin structure pathogens: global results of the Tigecycline Evaluation and Surveillance Trial","author":"Namdari","year":"2011","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.suc.2012.01.015_bib51","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.diagmicrobio.2009.07.010","article-title":"In\u00a0vitro activity of tigecycline and comparator agents against a global collection of Gram-negative and Gram-positive organisms: Tigecycline Evaluation and Surveillance Trial 2004-2007","volume":"65","author":"Garrison","year":"2009","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.suc.2012.01.015_bib52","first-page":"1519","article-title":"The prevalence of aminoglycoside-modifying enzyme genes (aac (6\u2032)-I, aac (6\u2032)-II, ant (2\u2032\u2032)-I, and aph (3\u2032)-VI) in Pseudomonas aeruginosa","volume":"66","author":"Vaziri","year":"2011","journal-title":"Clinics (Sao Paulo)"},{"issue":"Suppl 1","key":"10.1016\/j.suc.2012.01.015_bib53","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1086\/491711","article-title":"Vancomycin resistance in gram-positive cocci","volume":"42","author":"Courvalin","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.suc.2012.01.015_bib54","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/BF01963634","article-title":"Enterococcal resistance to vancomycin and related cyclic glycopeptide antibiotics","volume":"9","author":"Shlaes","year":"1990","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.suc.2012.01.015_bib55","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.mib.2010.08.006","article-title":"Epidemiology and clinical relevance of microbial resistance determinants versus anti-Gram positive agents","volume":"13","author":"Rossolini","year":"2010","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.suc.2012.01.015_bib56","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1086\/520655","article-title":"Perspectives on daptomycin resistance, with emphasis on resistance in Staphylococcus aureus","volume":"45","author":"Boucher","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.suc.2012.01.015_bib57","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.drup.2010.05.002","article-title":"Resistance to polymyxins: mechanisms, frequency, and treatment options","volume":"13","author":"Falagas","year":"2010","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.suc.2012.01.015_bib58","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1128\/CMR.00006-08","article-title":"Polymyxins revisited","volume":"21","author":"Landman","year":"2008","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.suc.2012.01.015_bib59","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.tim.2008.03.007","article-title":"The Salmonella PmrAB regulon: lipopolysaccharide modifications, antimicrobial peptide resistance and more","volume":"16","author":"Gunn","year":"2008","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.suc.2012.01.015_bib60","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1128\/AAC.00766-07","article-title":"Colistin heteroresistance in Acinetobacter and its association with previous colistin therapy","volume":"52","author":"Hawley","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.suc.2012.01.015_bib61","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.1128\/JCM.41.11.5113-5120.2003","article-title":"Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database","volume":"41","author":"McDougal","year":"2003","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.suc.2012.01.015_bib62","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1368-7646(03)00003-7","article-title":"Insights on antibiotic resistance of Staphylococcus aureus from its whole genome: genomic island SCC","volume":"6","author":"Ito","year":"2003","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.suc.2012.01.015_bib63","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1086\/344326","article-title":"A\u00a0novel methicillin resistance cassette in community-acquired methicillin-resistant Staphylococcus aureus isolates of diverse genetic backgrounds","volume":"186","author":"Daum","year":"2002","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.suc.2012.01.015_bib64","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3949\/ccjm.75.3.177","article-title":"Staphylococcus aureus: the new adventures of a legendary pathogen","volume":"75","author":"Rehm","year":"2008","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.suc.2012.01.015_bib65","doi-asserted-by":"crossref","first-page":"249","DOI":"10.7326\/0003-4819-148-4-200802190-00204","article-title":"Emergence of multidrug-resistant, community-acquired, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men","volume":"148","author":"Diep","year":"2008","journal-title":"Ann Intern Med"},{"issue":"Suppl","key":"10.1016\/j.suc.2012.01.015_bib66","doi-asserted-by":"crossref","first-page":"i3","DOI":"10.1093\/jac\/dkp256","article-title":"The changing epidemiology of resistance","volume":"64","author":"Hawley","year":"2009","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.suc.2012.01.015_bib67","first-page":"624","article-title":"Reduced susceptibility of Staphylococcus aureus to vancomycin: Japan, 1996","volume":"46","author":"Centers for Disease Control","year":"1997","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"Suppl 4","key":"10.1016\/j.suc.2012.01.015_bib68","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/S0924-8579(09)70562-X","article-title":"Risk factors and management of Gram-positive bacteraemia","volume":"34","author":"Cervera","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.suc.2012.01.015_bib69","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/cid\/cir078","article-title":"Vancomycin: we can\u2019t get there from here","volume":"52","author":"Patel","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.suc.2012.01.015_bib70","series-title":"Investigation and control of vancomycin-intermediate and-resistant Staphylococcus aureus: a guide for health departments and infection control personnel","author":"Hageman","year":"2006"},{"key":"10.1016\/j.suc.2012.01.015_bib71","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3201\/eid0702.010237","article-title":"Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus","volume":"7","author":"Tenover","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.suc.2012.01.015_bib72","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1128\/JCM.39.7.2439-2444.2001","article-title":"Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides","volume":"39","author":"Walsh","year":"2001","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.suc.2012.01.015_bib73","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1128\/JCM.43.5.2494-2496.2005","article-title":"Unstable vancomycin heteroresistance is common among clinical isolates of methicillin-resistant Staphylococcus aureus","volume":"43","author":"Plipat","year":"2005","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.suc.2012.01.015_bib74","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1146\/annurev.micro.56.012302.160806","article-title":"The prevalence and mechanisms of vancomycin resistance in Staphylococcus aureus","volume":"56","author":"Walsh","year":"2002","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.suc.2012.01.015_bib75","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1093\/jac\/dkr169","article-title":"Relevance of vancomycin-intermediate susceptibility and heteroresistance in methicillin-resistant Staphylococcus aureus bacteraemia","volume":"66","author":"Khatib","year":"2011","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.suc.2012.01.015_bib76","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/PAT.0b013e3283464ca3","article-title":"Challenges in the microbiological diagnosis and management of hVISA infections","volume":"43","author":"Cheong","year":"2011","journal-title":"Pathology"},{"key":"10.1016\/j.suc.2012.01.015_bib77","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1345\/aph.1M526","article-title":"Heterogeneous vancomycin resistance in Staphylococcus aureus: a review of epidemiology, diagnosis, and clinical significance","volume":"44","author":"Rong","year":"2010","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.suc.2012.01.015_bib78","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1128\/AAC.01133-10","article-title":"Systematic review and meta-analysis of the significance of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates","volume":"55","author":"Van Hal","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.suc.2012.01.015_bib79","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1089\/sur.2011.068","article-title":"The changing face of Staphylococcus aureus: a continuing surgical challenge","volume":"12","author":"Fry","year":"2011","journal-title":"Surg Infect (Larchmt)"},{"key":"10.1016\/j.suc.2012.01.015_bib80","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ijantimicag.2007.10.026","article-title":"Staphylococcus aureus small colony variants: a challenge to microbiologists and clinicians","volume":"31","author":"von Eiff","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.suc.2012.01.015_bib81","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/338782","article-title":"Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare","volume":"34","author":"Livermore","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.suc.2012.01.015_bib82","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1111\/j.1462-2920.2011.02495.x","article-title":"Key two-component regulatory systems that control biofilm formation in Pseudomonas aeruginosa","volume":"13","author":"Mikkelsen","year":"2011","journal-title":"Environ Microbiol"},{"key":"10.1016\/j.suc.2012.01.015_bib83","doi-asserted-by":"crossref","first-page":"879","DOI":"10.3349\/ymj.2011.52.6.879","article-title":"Multidrug-resistant Acinetobacter spp.: increasingly problematic nosocomial pathogens","volume":"52","author":"Lee","year":"2011","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.suc.2012.01.015_bib84","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1128\/AAC.01388-10","article-title":"Efflux-mediated antibiotic resistance in Acinetobacter spp","volume":"55","author":"Coyne","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.suc.2012.01.015_bib85","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/01.qco.0000171920.44809.f0","article-title":"Update on Pseudomonas aeruginosa and Acinetobacter baumannii infections in the healthcare setting","volume":"18","author":"Navon-Venezia","year":"2005","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.suc.2012.01.015_bib86","unstructured":"Available at: http:\/\/www.idsociety.org\/Content.aspx?id=17429. Accessed January 2, 2012."},{"key":"10.1016\/j.suc.2012.01.015_bib87","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.ajic.2009.10.001","article-title":"National Healthcare Safety Network (NHSN) report: data summary for 2006 through 2008, issued December 2009","volume":"37","author":"Edwards","year":"2009","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.suc.2012.01.015_bib88","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1055\/s-0031-1275525","article-title":"Epidemiology of infections acquired in intensive care units","volume":"32","author":"Doyle","year":"2011","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.suc.2012.01.015_bib89","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1067\/mic.2001.119952","article-title":"National Nosocomial Infections Surveillance System (NNIS) System Report: data summary from January 1992-June 2001, issued August 2001","volume":"29","year":"2001","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.suc.2012.01.015_bib90","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ajic.2004.10.001","article-title":"National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 to June 2004, issued October 2004","volume":"32","year":"2004","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.suc.2012.01.015_bib91","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ijantimicag.2010.07.002","volume":"38","author":"Hsieh","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.suc.2012.01.015_bib92","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1089\/sur.2008.0020","article-title":"In\u00a0vitro susceptibilities of aerobic and facultatively anaerobic gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2005 results from Study for Monitoring Antimicrobial Resistance Trends (SMART)","volume":"10","author":"Baquero","year":"2009","journal-title":"Surg Infect (Larchmt)"},{"key":"10.1016\/j.suc.2012.01.015_bib93","doi-asserted-by":"crossref","DOI":"10.1089\/sur.2011.074","article-title":"Antimicrobial susceptibility of gram-negative pathogens isolated from patients with complicated intra-abdominal infections in South African hospitals (SMART study 2004-2009): impact of the new carbapenem breakpoints","author":"Brink","year":"2012","journal-title":"Surg Infect (Larchmt)"},{"key":"10.1016\/j.suc.2012.01.015_bib94","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1089\/sur.2009.9930","article-title":"Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America","volume":"11","author":"Solomkin","year":"2010","journal-title":"Surg Infect (Larchmt)"},{"key":"10.1016\/j.suc.2012.01.015_bib95","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/2047-783X-16-3-115","article-title":"Antimicrobial treatment of \u201ccomplicated\u201d intra-abdominal infections and the new IDSA guidelines-a commentary and an alternative European approach according to clinical definitions","volume":"16","author":"Eckmann","year":"2011","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.suc.2012.01.015_bib96","doi-asserted-by":"crossref","first-page":"R20","DOI":"10.1186\/cc8877","article-title":"Risk factors for multidrug resistant bacteria and optimization of empirical antibiotic therapy in postoperative peritonitis","volume":"14","author":"Augustin","year":"2010","journal-title":"Crit Care"},{"key":"10.1016\/j.suc.2012.01.015_bib97","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/clinids\/23.3.486","article-title":"Emergence of antibiotic-resistant bacteria in cases of peritonitis after intraabdominal surgery affects the efficacy of empirical antimicrobial therapy","volume":"23","author":"Montravers","year":"1996","journal-title":"Clin Infect Dis"},{"issue":"Suppl 2","key":"10.1016\/j.suc.2012.01.015_bib98","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1086\/499406","article-title":"The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs","volume":"42","author":"Cosgrove","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.suc.2012.01.015_bib99","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1086\/653060","article-title":"Mortality, attributable mortality, and clinical events as end points for clinical trials of ventilator-associated pneumonia and hospital-acquired pneumonia","volume":"51","author":"Muscedere","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.suc.2012.01.015_bib100","article-title":"The adequacy of timely empiric antibiotic therapy for ventilator-associated pneumonia: an important determinant of outcome","author":"Muscedere","year":"2011","journal-title":"J\u00a0Crit Care"},{"key":"10.1016\/j.suc.2012.01.015_bib101","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1164\/ajrccm.159.4.9807050","article-title":"The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group","volume":"159","author":"Heyland","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.suc.2012.01.015_bib102","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1086\/345476","article-title":"Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis","volume":"36","author":"Cosgrove","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.suc.2012.01.015_bib103","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1128\/AAC.00182-09","article-title":"Impact of the different factors on the probability of clinical response in tigecycline-treated patients with intra-abdominal infections","volume":"54","author":"Bhavnani","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.suc.2012.01.015_bib104","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/infdis\/jir275","article-title":"Vancomycin minimum inhibitory concentration and outcome in patients with Staphylococcus aureus bacteremia: pearl or pellet?","volume":"204","author":"Holland","year":"2011","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.suc.2012.01.015_bib105","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/infdis\/jir270","article-title":"Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrations","volume":"204","author":"Holmes","year":"2011","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.suc.2012.01.015_bib106","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1517\/14656561003596350","article-title":"Treatment of Acinetobacter infections","volume":"11","author":"Michalopoulos","year":"2010","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.suc.2012.01.015_bib107","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-2466-10-45","article-title":"Imipenem resistance of Pseudomonas in pneumonia: a systematic literature review","volume":"10","author":"Zilberberg","year":"2010","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.suc.2012.01.015_bib108","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1517\/14656566.2011.599320","article-title":"Current review of antimicrobial treatment of nosocomial pneumonia caused by multidrug-resistant pathogens","volume":"12","author":"Jean","year":"2011","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.suc.2012.01.015_bib109","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1086\/603527","article-title":"Risk factors and outcomes associated with isolation of meropenem high-level-resistant Pseudomonas aeruginosa","volume":"30","author":"Eagye","year":"2009","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.suc.2012.01.015_bib110","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jhin.2010.09.010","article-title":"High level cephalosporin-resistant Enterobacteriaceae ventilator-associated pneumonia: prognostic factors based on a cohort study","volume":"77","author":"Aubron","year":"2011","journal-title":"J\u00a0Hosp Infect"},{"key":"10.1016\/j.suc.2012.01.015_bib111","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1099\/jmm.0.029439-0","article-title":"Clinical and microbiological characterization of carbapenem-resistant Acinetobacter baumannii bloodstream infections","volume":"60","author":"Song","year":"2011","journal-title":"J\u00a0Med Microbiol"},{"key":"10.1016\/j.suc.2012.01.015_bib112","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.diagmicrobio.2010.10.013","article-title":"Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections","volume":"69","author":"Neuner","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"Suppl 2","key":"10.1016\/j.suc.2012.01.015_bib113","doi-asserted-by":"crossref","first-page":"ii25","DOI":"10.1093\/jac\/dkq516","article-title":"Antibiotic dosing in critical illness","volume":"66","author":"McKenzie","year":"2011","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.suc.2012.01.015_bib114","first-page":"95","article-title":"Architecture and physiology of microbial biofilms","volume":"69","author":"Lazar","year":"2010","journal-title":"Roum Arch Microbiol Immunol"},{"key":"10.1016\/j.suc.2012.01.015_bib115","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1073\/pnas.0407661102","article-title":"Transient interference with staphylococcal quorum sensing blocks abscess formation","volume":"102","author":"Wright","year":"2005","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.suc.2012.01.015_bib116","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1089\/sur.2007.080","article-title":"The use of extended-interval aminoglycoside dosing strategies for the treatment of moderate-to-severe infections encountered in critically ill surgical patients","volume":"10","author":"Mueller","year":"2009","journal-title":"Surg Infect (Larchmt)"},{"key":"10.1016\/j.suc.2012.01.015_bib117","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1128\/AAC.42.7.1842","article-title":"Dosing of aminoglycosides to rapidly\u00a0attain pharmacodynamic goals and hasten therapeutic response by using\u00a0individualized pharmacokinetic monitoring of patients with pneumonia caused by gram-negative organisms","volume":"42","author":"Kashuba","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.suc.2012.01.015_bib118","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1128\/AAC.42.3.521","article-title":"Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy","volume":"42","author":"Thomas","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.suc.2012.01.015_bib119","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1128\/AAC.40.3.691","article-title":"Continuous infusion versus intermittent administration of ceftazidime in critically ill patients with suspected Gram-negative infections","volume":"40","author":"Benko","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.suc.2012.01.015_bib120","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1128\/AAC.00329-06","article-title":"Randomized, open-label, comparative study of piperacillin-tazobactam administered by continuous infusion versus intermittent infusion for treatment of hospitalized patients with complicated intra-abdominal infection","volume":"50","author":"Lau","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.suc.2012.01.015_bib121","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1089\/sur.2005.6.41","article-title":"Influence of antibiotic therapy on mortality of critical surgical illness caused or complicated by infection","volume":"6","author":"Barie","year":"2005","journal-title":"Surg Infect (Larchmt)"},{"key":"10.1016\/j.suc.2012.01.015_bib122","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/01.CCM.0000217961.75225.E9","article-title":"Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock","volume":"34","author":"Kumar","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1016\/j.suc.2012.01.015_bib123","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/01.CCM.0000298158.12101.41","volume":"36","author":"Dellinger","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1016\/j.suc.2012.01.015_bib124","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1097\/01.CCM.0000171849.04952.79","article-title":"Strategies to prevent antimicrobial resistance in the intensive care unit","volume":"33","author":"Kollef","year":"2005","journal-title":"Crit Care Med"},{"key":"10.1016\/j.suc.2012.01.015_bib125","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1093\/cid\/cir063","article-title":"Strategies for reduction in duration of antibiotic use in hospitalized patients","volume":"52","author":"Hayashi","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.suc.2012.01.015_bib126","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1086\/504486","article-title":"Novel antibiotic combinations against infections with almost completely resistant Pseudomonas aeruginosa and Acinetobacter species","volume":"43","author":"Rahal","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.suc.2012.01.015_bib127","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/01.CCM.0000297956.27474.9D","article-title":"Empiric antibiotic therapy for suspected ventilator-associated pneumonia: a systematic review and meta-analysis of randomized trials","volume":"36","author":"Aarts","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1016\/j.suc.2012.01.015_bib128","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1136\/bmj.38028.520995.63","article-title":"Beta-lactam monotherapy versus beta-lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomized trials","volume":"328","author":"Paul","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.suc.2012.01.015_bib129","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1097\/CCM.0b013e3181eb3ccd","article-title":"Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: a propensity-matched analysis","volume":"38","author":"Kumar","year":"2010","journal-title":"Crit Care Med"},{"key":"10.1016\/j.suc.2012.01.015_bib130","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1164\/rccm.200302-199OC","article-title":"Decision analysis of antibiotic and diagnostic strategies in ventilator-associated pneumonia","volume":"168","author":"Ost","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.suc.2012.01.015_bib131","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200405-644ST","article-title":"Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia","volume":"171","author":"American Thoracic Society","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.suc.2012.01.015_bib132","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1378\/chest.128.4.2706","article-title":"Antibiotic utilization and outcomes for patients with clinically suspected VAP and negative quantitative BAL cultures results","volume":"128","author":"Kollef","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.suc.2012.01.015_bib133","doi-asserted-by":"crossref","DOI":"10.2174\/138920111798808248","article-title":"Physiological changes in the critically ill patient with sepsis","author":"Hosein","year":"2011","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.suc.2012.01.015_bib134","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/jac\/dkq348","article-title":"Pharmacodynamics of empirical antibiotic monotherapies for an intensive care unit (ICU) population based on Canadian surveillance data","volume":"66","author":"Zelenitsky","year":"2011","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.suc.2012.01.015_bib135","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1086\/600877","article-title":"Vancomycin therapeutic guidelines: a summary of consensus recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists","volume":"49","author":"Rybak","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.suc.2012.01.015_bib136","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1093\/cid\/cir034","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.suc.2012.01.015_bib137","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1086\/600884","article-title":"Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients","volume":"49","author":"Lodise","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.suc.2012.01.015_bib138","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/jac\/dkq449","article-title":"Monte Carlo simulations: maximizing antibiotic pharmacokinetic data to optimize clinical practice for critically ill patients","volume":"66","author":"Roberts","year":"2011","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.suc.2012.01.015_bib139","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s00134-010-2105-0","article-title":"Optimization of meropenem dosage in the critically ill population based on renal function","volume":"37","author":"Crandon","year":"2011","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.suc.2012.01.015_bib140","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1128\/AAC.01141-08","article-title":"Population pharmacokinetics of high-dose, prolonged-infusion cefepime in adult critically ill patients with ventilator-associated pneumonia","volume":"53","author":"Nicasio","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.suc.2012.01.015_bib141","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1016\/j.clinthera.2009.11.026","article-title":"Probability of pharmacodynamic target attainment with standard and prolonged-infusion antibiotic regimens for empiric therapy in adults with hospital-acquired pneumonia","volume":"31","author":"Kim","year":"2009","journal-title":"Clin Ther"},{"key":"10.1016\/j.suc.2012.01.015_bib142","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1089\/sur.2005.6.419","article-title":"Pharmacodynamic modeling of imipenem-cilastatin, meropenem, and piperacillin-tazobactam for empiric therapy of skin and soft tissue infections: a report from the OPTAMA Program","volume":"6","author":"Ong","year":"2005","journal-title":"Surg Infect (Larchmt)"},{"key":"10.1016\/j.suc.2012.01.015_bib143","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1089\/sur.2005.6.297","article-title":"Pharmacodynamic modeling of beta-lactam antibiotics for the empiric treatment of secondary peritonitis: a report from the OPTAMA program","volume":"6","author":"Kotapati","year":"2005","journal-title":"Surg Infect (Larchmt)"},{"key":"10.1016\/j.suc.2012.01.015_bib144","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1086\/510590","article-title":"Piperacillin-tazobactam for Pseudomonas aeruginosa infection: clinical implications of an extended-infusion dosing strategy","volume":"44","author":"Lodise","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.suc.2012.01.015_bib145","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1592\/phco.31.6.527","article-title":"High-dose daptomycin for treatment of complicated gram-positive infections: a large multicenter, retrospective study","volume":"31","author":"Kullar","year":"2011","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.suc.2012.01.015_bib146","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1093\/jac\/dkr066","article-title":"Daptomycin non-susceptibility in vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous-VISA (hVISA): implications for therapy after vancomycin treatment failure","volume":"66","author":"Kelley","year":"2011","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.suc.2012.01.015_bib147","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1128\/AAC.01420-10","article-title":"Double-carbapenem therapy for carbapenemase-producing Klebsiella pneumoniae","volume":"55","author":"Bulik","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.suc.2012.01.015_bib148","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1128\/JCM.01106-10","article-title":"In\u00a0vitro evaluation of antibiotic synergy for\u00a0polymyxin B-resistant carbapenemase-producing Klebsiella pneumoniae","volume":"48","author":"Elemam","year":"2010","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.suc.2012.01.015_bib149","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/j.1469-0691.2011.03553.x","article-title":"Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems?","volume":"17","author":"Daikos","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.suc.2012.01.015_bib150","article-title":"In\u00a0vitro time-kill studies of antimicrobial agents against blood isolates of imipenem-resistant Acinetobacter baumannii including colistin-or tigecycline-resistant strains","author":"Peck","year":"2011","journal-title":"J\u00a0Med Microbiol"},{"key":"10.1016\/j.suc.2012.01.015_bib151","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1055\/s-0031-1275527","article-title":"New treatment options for infections caused by multiresistant strains of Pseudomonas aeruginosa and other non-fermenting gram-negative bacilli","volume":"32","author":"Sanchez","year":"2011","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.suc.2012.01.015_bib152","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijantimicag.2008.11.006","article-title":"Tigecycline in combination with other antimicrobials: a review of in\u00a0vitro, animal, and case report studies","volume":"34","author":"Entenza","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.suc.2012.01.015_bib153","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00228-010-0794-5","article-title":"Synergy of fosfomycin with other antibiotics for Gram-positive and Gram-negative bacteria","volume":"66","author":"Kastoris","year":"2010","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.suc.2012.01.015_bib154","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1128\/AAC.00065-10","article-title":"The combination of meropenem and levofloxacin is synergistic with respect to both Pseudomonas aeruginosa kill rate and resistance suppression","volume":"54","author":"Grasso","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.suc.2012.01.015_bib155","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2165\/11318430-000000000-00000","article-title":"Current challenges in antimicrobial chemotherapy: focus on \u03b2-lactamase inhibition","volume":"70","author":"Bebrone","year":"2010","journal-title":"Drugs"},{"key":"10.1016\/j.suc.2012.01.015_bib156","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ijantimicag.2011.01.017","article-title":"Ceftaroline: a comprehensive update","volume":"37","author":"Kaushik","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.suc.2012.01.015_bib157","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/jac\/dkl354","article-title":"Two decades of imipenem therapy","volume":"58","author":"Rodloff","year":"2006","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.suc.2012.01.015_bib158","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1586\/14787210.3.1.23","article-title":"Ertapenem: review of a new carbapenem","volume":"31","author":"Zhanel","year":"2005","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.suc.2012.01.015_bib159","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/cid\/cir124","article-title":"Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guideline suggested targets","volume":"52","author":"Kullar","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.suc.2012.01.015_bib160","unstructured":"FDA lowers breakpoints for staph infections. Available at: http:\/\/news.idsociety.org\/idsa\/issues\/2008-05-01. Accessed June 20, 2011."},{"key":"10.1016\/j.suc.2012.01.015_bib161","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1016\/S0149-2918(11)00020-8","article-title":"Telavancin: a lipoglycopeptide antibiotic for the treatment of complicated skin and skin structure infections caused by gram-positive bacteria in adults","volume":"32","author":"Chang","year":"2010","journal-title":"Clin Ther"},{"key":"10.1016\/j.suc.2012.01.015_bib162","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1086\/430352","article-title":"Inhibition of daptomycin by pulmonary surfactant: in\u00a0vitro modeling and clinical impact","volume":"191","author":"Silverman","year":"2005","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.suc.2012.01.015_bib163","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1517\/14656560903334185","article-title":"New information about the polymyxin\/colistin class of antibiotics","volume":"10","author":"Molina","year":"2009","journal-title":"Expert Opin Pharmacol"},{"key":"10.1016\/j.suc.2012.01.015_bib164","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1086\/505494","article-title":"Tigecycline: a critical analysis","volume":"43","author":"Stein","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.suc.2012.01.015_bib165","first-page":"273","article-title":"Tigecycline in the treatment of infections from multi-drug resistant gram-negative pathogens","volume":"58","author":"Poulakou","year":"2009","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.suc.2012.01.015_bib166","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/jac\/dkn165","article-title":"Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence","volume":"62","author":"Karageorgopoulos","year":"2008","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"Suppl 1","key":"10.1016\/j.suc.2012.01.015_bib167","doi-asserted-by":"crossref","first-page":"i29","DOI":"10.1093\/jac\/dkn249","article-title":"A\u00a0phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii, and Klebsiella pneumoniae","volume":"62","author":"Vasilev","year":"2008","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.suc.2012.01.015_bib168","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000329406","article-title":"Prospective, non-interventional, multi-centre trial of tigecycline in the treatment of severely ill patients with complicated infections-new insights into clinical results and treatment practice","volume":"57","author":"Eckmann","year":"2011","journal-title":"Chemotherapy"},{"key":"10.1016\/j.suc.2012.01.015_bib169","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/1471-2334-10-287","article-title":"Tigecycline use in serious nosocomial infections: a drug use evaluation","volume":"10","author":"Bassetti","year":"2010","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.suc.2012.01.015_bib170","unstructured":"Available at: www.fda.gov\/Drugs\/DrugSafety\/ucm224370.htm. Accessed June 8, 2011."},{"key":"10.1016\/j.suc.2012.01.015_bib171","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1128\/AAC.01402-10","article-title":"Systematic review and meta-analysis of the effectiveness and safety of tigecycline for treatment of infectious disease","volume":"55","author":"Cai","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.suc.2012.01.015_bib172","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1186\/2047-783X-15-12-554","article-title":"Treatment of complicated skin and soft-tissue infections caused by resistant bacteria: value of linezolid, tigecycline, daptomycin and vancomycin","volume":"15","author":"Eckmann","year":"2010","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.suc.2012.01.015_bib173","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1378\/chest.10-1556","article-title":"Linezolid vs. glycopeptide antibiotics for the treatment of suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia","volume":"139","author":"Walkey","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.suc.2012.01.015_bib174","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/01.CCM.0000152230.53473.A1","article-title":"First-generation fluoroquinolone use and subsequent emergence of multiple drug-resistant bacteria in the intensive care unit","volume":"33","author":"Nseir","year":"2005","journal-title":"Crit Care Med"},{"key":"10.1016\/j.suc.2012.01.015_bib175","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.tim.2006.07.008","article-title":"The beta-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter","volume":"14","author":"Livermore","year":"2006","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.suc.2012.01.015_bib176","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1086\/500319","article-title":"Fluoroquinolone use and methicillin-resistant Staphylococcus aureus isolation rates in hospitalized patients: a quasi experimental study","volume":"42","author":"Charbonneau","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.suc.2012.01.015_bib177","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jcrc.2007.12.006","article-title":"The safety of targeted antibiotic therapy for ventilator-associated pneumonia: a multi-center observational study","volume":"23","author":"Joffe","year":"2008","journal-title":"J\u00a0Crit Care"},{"key":"10.1016\/j.suc.2012.01.015_bib178","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1097\/CCM.0b013e3181f17bf9","article-title":"Procalcitonin-guided algorithms of antibiotic therapy in the intensive care unit: a systematic review and meta-analysis of randomized controlled trials","volume":"38","author":"Kopterides","year":"2010","journal-title":"Crit Care Med"},{"key":"10.1016\/j.suc.2012.01.015_bib179","unstructured":"Siegel JD, Rhinehart E, Jackson M, et\u00a0al. The Healthcare Infection Control Practices Advisory Committee. Management of multidrug-resistant organisms in healthcare settings, 2006. Available at: http:\/\/www.cdc.gov\/hicpac\/mdro\/mdro_2.html. Accessed June 8, 2011."},{"key":"10.1016\/j.suc.2012.01.015_bib180","unstructured":"Siegel JD, Rhinehart E, Jackson M, et\u00a0al. Healthcare Infection Control Practices Advisory Committee. 2007 Guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings. Available at: http:\/\/www.cdc.gov\/ncidod\/dhqp\/pdf\/isolation2007.pdf. Accessed June 8, 2011."},{"key":"10.1016\/j.suc.2012.01.015_bib181","series-title":"Guidelines for environmental infection control in health-care facilities. Recommendations from CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC)","author":"Sehulster","year":"2004"},{"key":"10.1016\/j.suc.2012.01.015_bib182","unstructured":"Boyce JM, Pittet D. Guideline for hand hygiene in health-care settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC\/SHEA\/APIC\/IDSA Hand Hygiene Task Force. Available at: www.cdc.gov\/mmwr\/preview\/mmwrhtml\/rr5116a1.htm. Accessed June 8, 2011."},{"key":"10.1016\/j.suc.2012.01.015_bib183","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/clinids\/23.1.118","article-title":"Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center","volume":"23","author":"Rice","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.suc.2012.01.015_bib184","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1086\/501787","article-title":"Association of antibiotic utilization measures and control of multiple-drug resistance in Klebsiella pneumoniae","volume":"21","author":"Patterson","year":"2000","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.suc.2012.01.015_bib185","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1086\/338639","article-title":"Nosocomial gram-negative resistance in multiple gram-negative species: experience at one hospital with squeezing the resistance balloon at multiple sites","volume":"34","author":"Rahal","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"4 Pt 1","key":"10.1016\/j.suc.2012.01.015_bib186","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1164\/ajrccm.156.4.9701046","article-title":"Scheduled change of antibiotic classes: a strategy to decrease the incidence of ventilator-associated pneumonia","volume":"156","author":"Kollef","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.suc.2012.01.015_bib187","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/jac\/dkl097","article-title":"Impact of diversity of antibiotic use on development of antimicrobial resistance","volume":"57","author":"Sandiumenge","year":"2006","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.suc.2012.01.015_bib188","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1749-6632.2010.05867.x","article-title":"Antibiotic heterogeneity: from concept to practice","volume":"1213","author":"Bal","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.suc.2012.01.015_bib189","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1097\/00003246-200106000-00001","article-title":"Impact of a rotating empiric antibiotic schedule on infectious mortality in an intensive care unit","volume":"29","author":"Raymond","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1016\/j.suc.2012.01.015_bib190","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1089\/sur.2007.024","article-title":"Reduction in rates of methicillin-resistant Staphylococcus aureus infection after introduction of quarterly linezolid-vancomycin cycling in a surgical intensive care unit","volume":"9","author":"Smith","year":"2008","journal-title":"Surg Infect (Larchmt)"},{"key":"10.1016\/j.suc.2012.01.015_bib191","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.suc.2008.09.011","article-title":"Preventing bacterial resistance in surgical patients","volume":"89","author":"Evans","year":"2009","journal-title":"Surg Clin North Am"},{"key":"10.1016\/j.suc.2012.01.015_bib192","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1089\/sur.2009.059","article-title":"Infection reduction strategies including antibiotic stewardship protocols in surgical and trauma intensive care units are associated with reduced resistant gram-negative healthcare-associated infections","volume":"12","author":"Dortch","year":"2011","journal-title":"Surg Infect (Larchmt)"},{"key":"10.1016\/j.suc.2012.01.015_bib193","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1089\/sur.2008.047","article-title":"Need for both antibiotic cycling and stringent environmental controls to prevent Pseudomonas infections","volume":"10","author":"Curtis","year":"2009","journal-title":"Surg Infect (Larchmt)"}],"container-title":["Surgical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039610912000291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039610912000291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,4]],"date-time":"2020-07-04T01:58:11Z","timestamp":1593827891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039610912000291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":193,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0039610912000291"],"URL":"https:\/\/doi.org\/10.1016\/j.suc.2012.01.015","relation":{},"ISSN":["0039-6109"],"issn-type":[{"value":"0039-6109","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}